UK Markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
145.10-4.08 (-2.73%)
At close: 4:00PM EDT

144.73 -0.37 (-0.25%)
After hours: 4:26PM EDT

Sign in to post a message.
  • J
    How does this forum feel about $JNJ? I bought 10 shares in Feb 2018 and have reinvested dividends ever since. However, I’ve only seen 10% gain over that time. I may just sell it altogether. Am I getting out at the wrong time?
  • o
    If you’re a day trader, you should definitely check out They send a watchlist covering the top pre-market movers every day before the open. It’s a great way to pick out potential trades for the day.
  • B
    I would love to see JNJ either acquire or partner with a tiny biotech symbol ( the name is a real tongue twister) NNVC. They have the most unique concept in treating diseases. Their outside the box thinking completely bypasses the immune system. This could really be a game changer. They explain it very clearly on their website.
  • j
    JNJ is the only company with a vaccine that does not need special storage like -94 F or applying multiple shot like PFE and MRNA.
    After all, JNJ is testing 60k people all over the world while others are limited to a few thousands. PFE is after JNJ with 30k people but PFE is wasting it time with a vaccine that need -94 F storage.
  • C
    $ARWR conversation
    The Ravid on Twitter this morning :$ARWR has vast pipeline including several later stage assets, partnership with Janssen $JNJ for multiple assets, license with Amgen $AMGN; if they do 1 drug w/$1B sales @ 4x multiple (on a sale), you cover the current valuation, get the rest of platform and pipeline free.
  • D
    Dirty John
    This must be the least exciting stock in the stock market lol
  • S
    Monday morning announcement: a partnership between JNJ and Vaxart.
  • A
    You know you have a winner when there's not a lot of stock pumping going on a chat board . Slow gains all day long
  • M
    Deborah, I just mute them.
  • K
    06:46 AM EDT, 08/31/2020 (MT Newswires) -- Actelion Pharmaceuticals, a Janssen Pharmaceutical company of Johnson & Johnson (JNJ), on Saturday said that the primary endpoint of the Phase 3b TRITON trial was not met, but exploratory analysis suggests a signal of reduced risk of disease progression of initial triple oral combination therapy versus initial double oral therapy for patients with pulmonary arterial hypertension
  • y
    Very strong resistance @149.50
  • S
    I like the business but too much risk. Now, NY state is going after JNJ.
  • L
    hi guys I'm new I just have a question...why regeneron only has 64 billion market cap meanwhile this company have 400 bill market cap but regenerons sp is higher? thnks
  • f
    Yes someone did buy almost $600 million worth of JNJ and VXRT just before the close. It could be anything, an endorsement, a buyout, anything.
  • L
    Why all the gloom and doom? The Economy is doing wonderful and the Stock Market is proof. We need to have faith in our politicians to do the right thing in the futureand not the political thing as in the past. Just look at the past 8 months, only 190,000 dead folks, as said could have been much worse. Pray for us, we need it.
  • C
    Aug 19 (Reuters) - Johnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals Inc for about $6.5 billion in cash to expand into the area of autoimmune disease treatments.
  • J
    JNJ is possibly the most diversified company in the world. They sell fantastic products from birth to grave.
  • E
    Is it going hit 151?
  • k
    I love the comments in JNJ .Find the people who are veterans in investing.
  • M
    $CYDY conversation
    So, folks, what are your bets for tonight 6:00 pm ET?
    1. leronlimab by $CYDY
    2. remstemcell-L/Ryoncil by $MESO
    3. aviptadil/VIP by $RLFTF
    4. anti-spike antibodies by $REGN
    5. anti-spike antibodies by $LLY
    6. oleandrin
    7. some vaccine ($MRNA, $NVAX, $AZN, $INO, $JNJ, $PFE, $SNY, $GSK)
    8. novel disinfectant
    9. something else
    Trump will hold a press conference at around 6:00 pm ET on August 23 to discuss "a major therapeutic breakthrough" regarding COVID-19.
    Trump will hold a press conference at around 6:00 pm ET on August 23 to discuss "a major therapeutic breakthrough" regarding COVID-19.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more